BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | A212756 | DIFGEN PHARMACEUTICALS LLC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Indivior Inc. et al v. Aveva Drug Delivery Systems, Inc. et al 4 patentsANDA 212756buprenorphine hydrochloride and naloxone hydrochloride | S.D. Fla. | 2019-03-22 | Terminated 2019-11-19 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.